JPTRM Vol. 11 No. 2 (November 2023)
Permanent URI for this collection
Browse
Browsing JPTRM Vol. 11 No. 2 (November 2023) by Subject "Amyotrophic lateral sclerosis"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Persea Americana’s Extract Could Offer Effective Treatment for Amyotrophic Lateral Sclerosis: A Hypothesis(Chitkara University Publications, 2023-11-10) Sukriti Vishwas; Bushra Bashir; Nikhil B. Khandale; Sachin Kumar Singh; Uma DeviBackground: Amyotrophic lateral sclerosis (ALS) is a rare neurodegener-ative disease characterized by the degeneration of upper and lower motor neurons in the central and peripheral nervous systems. Several patholog-ical conditions, including neuroinflammation, oxidative stress, and mito-chondrial dysfunction, contribute to the degeneration of motor neurons. Despite extensive research, no current drug therapies have proven effec-tive in treating ALS. Purpose: This study explores the therapeutic potential of Persea americana (PA) Mill, commonly known as avocado, in the treatment of ALS. Methods: The review draws on pre-clinical and clinical studies that have demonstrated the neuroprotective effects of PA extracts (PAE) in diseas-es such as Alzheimer’s and Parkinson’s, highlighting the potential mechanisms that may be relevant to ALS. Results: Although no studies have directly investigated the effects of PA on ALS, the bioactive compounds in PA have shown promising results in mitigating neurodegenerative processes through their diverse biological activities. Conclusion: Based on existing evidence from related neurodegenerative conditions and the mechanisms involved in ALS pathology, it is hypothesized that PA extracts may offer a novel therapeutic avenue for ALS. Further research is required to validate the efficacy of PAE in man-aging ALS symptoms and slowing disease progression.